Takeda Pharmaceutical Co. Ltd. Release: TROPHY Study Confirms Cardesartan Cilexetil Reduces Risk Of Hypertension

Tokyo, Mar 17, 2006 (JCN) - Takeda Pharmaceutical recently announced that the results of the TROPHY (Trial of Preventing Hypertension) study were published in the March 14 issue of the online version of the New England Journal of Medicine.